Anti-ganglioside antibodies and elevated CSF IgG levels in Guillain-Barré syndrome

European Journal of Neurology

Volumn 13, Issue 2, 2006, Pages 153-160

  Mata S ^a   Galli, E ^a   Amantini, A ^a   Pinto, F ^a   Sorbi, S ^a   Lolli, F ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

Author keywords

Anti ganglioside antibody; Blood CSF barrier; F wave; Guillain Barr syndrome; Immunoglobulin

Indexed keywords

GANGLIOSIDE ANTIBODY; IMMUNOGLOBULIN G; OLIGOCLONAL BAND;

ADOLESCENT; ADULT; AGED; ANTIBODY PRODUCTION; ANTIBODY TITER; ARTICLE; BLOOD CEREBROSPINAL FLUID BARRIER; CEREBROSPINAL FLUID ANALYSIS; CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY; CONTROLLED STUDY; DISEASE ASSOCIATION; ELECTROPHYSIOLOGY; FEMALE; GUILLAIN BARRE SYNDROME; HUMAN; IMMUNOGLOBULIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; MOTOR NERVE CONDUCTION; NERVE ROOT INJURY; NEUROLOGIC DISEASE; PRIORITY JOURNAL;

ACTION POTENTIALS; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTIBODIES, ANTI-IDIOTYPIC; CENTRAL NERVOUS SYSTEM DISEASES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GANGLIOSIDES; GUILLAIN-BARRE SYNDROME; HUMANS; IMMUNOGLOBULIN G; LINEAR MODELS; MALE; MIDDLE AGED; NEURAL CONDUCTION; STATISTICS, NONPARAMETRIC;

EID: 33645235812     PISSN: 13515101     EISSN: 14681331     Source Type: Journal    
DOI: 10.1111/j.1468-1331.2006.01161.x     Document Type: Article

References (36)

1. Asbury AK Cornblath DR. Assessment of current diagnostic criteria for Guillain-Barré syndrome. Annals of Neurology 1990 27 S21 S24.
2. Link H. Demonstration of oligoclonal immunoglobulin G in Guillain-Barré syndrome. Acta Neurologica Scandinavica 1975 52 111 120.
3. Roberts-Thomson PJ Esiri MM Young AC Maclennan IC. Cerebrospinal fluid immunoglobulin quotients, kappa/lambda ratios, and viral antibody titres in neurological disease. Journal of Clinical Pathology 1976 29 1105 1115.
4. Vedeler CA Matre R Nyland H. Immunoglobulins in serum and cerebrospinal fluid from patients with acute Guillain-Barré syndrome. Acta Neurologica Scandinavica 1986 73 388 393.
5. Kieseier BC Dalakas MC Hartung HP. Immune mechanisms in chronic inflammatory demyelinating neuropathy. Neurology 2002 59 Suppl. 6 S7 S12.
6. Willison HJ Yuki N. Peripheral neuropathies and anti-glycolipid antibodies. Brain 2002 125 2591 2625.
7. Thomas FP Trojaborg W Nagy C et al. Experimental autoimmune neuropathy with anti-GM1 antibodies and immunoglobulin deposits at the nodes of Ranvier. Acta Neuropathologica 1991 82 378 383.
8. Santoro M Uncini A Corbo M Staugaitis SM Thomas FP Hays AP. Experimental conduction block induced by serum from a patient with anti-GM1 antibodies. Annals of Neurology 1992 31 385 390.
9. Uncini A Santoro M Corbo M Lugaresi A Latov N. Conduction abnormalities induced by sera of patients with multifocal motor neuropathy and anti-GM1 antibodies. Muscle and Nerve 1993 16 610 615.
10. Weber F Rudel R Aulkemeyer P Brinkmeier H. Anti-GM1 antibodies block neuronal voltage-gated sodium channels. Muscle and Nerve 2000 23 1414 1420.
11. Kanda T Yamawaki M Iwasaki T Mizusawa H. Glycosphingolipid antibodies and blood-nerve barrier in demyelinative neuropathy. Neurology 2000 54 1459 1464.
12. Ad Hoc Subcommittee of the American Academy of Neurology AIDS Task Force. Research criteria for diagnosis of chronic inflammatory demyelinating polyradiculoneuropathy (CIDP). Neurology 1991 41 617 618.
13. Hughes RA Newsom-Davis JM Perkin GD Pierce JM. Controlled trial prednisolone in acute polyneuropathy. Lancet 1978 2 750 753.
14. Hadden RD Cornblath DR Hughes RA et al. Electrophysiological classification of Guillain-Barré syndrome: clinical associations and outcome. Plasma Exchange/Sandoglobulin Guillain-Barré Syndrome Trial Group. Annals of Neurology 1998 44 780 8.
15. Link H. Immunoglobulin G and low molecular weight proteins in human cerebrospinal fluid. Chemical and immunological characterisation with special reference to multiple sclerosis. Acta Neurologica Scandinavica 1967 43 Suppl. 28 1 136.
16. Delpech B Lichtblau E. Etude quantitative des immunoglobulines G et de l'albumine du liquid céphalo rachidien. Clinica Chimica Acta 1972 37 15 23.
17. Lefvert AK Link H. IgG production within the central nervous system: a critical review of proposed formulae. Annals of Neurology 1985 17 13 20.
18. Reiber H Felgenhauer K. Protein transfer at the blood cerebrospinal fluid barrier and the quantitation of the humoral immune response within the central nervous system. Clinica Chimica Acta 1987 163 319 328.
19. Reiber H. Flow rate of cerebrospinal fluid (CSF) - a concept common to normal blood-CSF barrier function and to dysfunction in neurological diseases. Journal of the Neurological Sciences 1994 122 189 203.
20. Dart GC Kaldor J. Immunoglobulins in the cerebrospinal fluid of patients with Guillain-Barré syndrome. Medical Journal of Australia 1981 2 405 407.
21. Tijssen P. Practice and theory of enzyme immunoassays. In Burbon RH van Knippenberg PH. eds. Laboratory Techniques in Biochemistry and Molecular Biology Vol. 15.
22. Reiber H Lange P. Quantification of virus-specific antibodies in cerebrospinal fluid and serum: sensitive and specific detection of antibody synthesis in brain. Clinical Chemistry 1991 37 1153 1160.
23. Nobile-Orazio E Carpo M Meucci N et al. Guillain-Barré syndrome associated with high titers of anti-GM1 antibodies. Journal of the Neurological Sciences 1992 109 200 206.
24. Kusunoki S. Antiglycolipid antibodies in Guillain-Barré syndrome and autoimmune neuropathies. American Journal of the Medical Sciences 2000 319 234 239.
25. Vriesendorp FJ Triggs WJ Mayer RF Koski CL. Electrophysiological studies in Guillain-Barré syndrome: correlation with antibodies to GM1, GD1B and Campylobacter jejuni. Journal of Neurology 1995 242 460 465.
26. Kuwabara S Yuki N Koga M et al. IgG anti-GM1 antibody is associated with reversible conduction failure and axonal degeneration in Guillain-Barré syndrome. Annals of Neurology 1998 44 202 208.
27. Hirota N Kaji R Bostock H et al. The physiological effect of anti-GM1 antibodies on saltatory conduction and transmembrane currents in single motor axons. Brain 1997 120 2159 2169.
28. Paparounas K O'Hanlon GM O'Leary CP Rowan EG Willison HJ. Anti-ganglioside antibodies can bind peripheral nerve nodes of Ranvier and activate the complement cascade without inducing acute conduction block in vitro. Brain 1999 122 807 816.
29. Kuwabara S Ogawara K Mizobuchi K et al. Isolated absence of F waves and proximal axonal dysfunction in Guillain-Barré syndrome with antiganglioside antibodies. Journal of Neurology, Neurosurgery and Psychiatry 2000 68 191 195.
30. Segurado OG Kruger H Mertens HG. Clinical significance of serum and CSF findings in the Guillain-Barré syndrome and related disorders. Journal of Neurology 1986 233 202 208.
31. Araga S Kagimoto H Adachi A Funamoto K Inoue K Takahashi K. Kappa/lambda ratios of IgG, IgA and IgM in the cerebrospinal fluid of patients with Guillain-Barré syndrome. Japanese Journal of Medicine 1991 30 118 122.
32. Hadden RD Gregson NA Gold R Smith KJ Hughes RA. Accumulation of immunoglobulin across the 'blood-nerve barrier' in spinal roots in adoptive transfer experimental autoimmune neuritis. Neuropathology and Applied Neurobiology 2002 28 489 497.
33. Kanda T Yamawaki M Mizusawa H. Sera from Guillain-Barré patients enhance leakage in blood-nerve barrier model. Neurology 2003 60 301 306.
34. Vorbrodt AW. Ultracytochemical characterization of anionic sites in the wall of brain capillaries. Journal of Neurocytology 1989 18 359 368.
35. Wollinsky KH Hulser PJ Brinkmeier H et al. CSF filtration is an effective treatment of Guillain-Barré syndrome: a randomized clinical trial. Neurology 2001 57 774 780.
36. Smith KJ Hall SM. Factors directly affecting impulse transmission in inflammatory demyelinating disease: recent advances in our understanding. Current Opinion in Neurology 2001 14 289 298.